Weight Loss And ...

What if the medications that were supposed to fix obesity turned out to be just the beginning of the story? After decades of studying weight loss, Holly and Jim thought they had seen it all. Then a new class of medications arrived and overturned some of their most basic assumptions.In this episode, each of them brings five things that genuinely surprised them about the GLP-1 era. Some are about the science, some are about what they see in patients, and some are about what these medications were expected to solve but haven't. Two longtime experts admit what they got wrong, what they're still puzzling over, and where they disagree. Join Holly and Jim for a candid look at where obesity treatment stands now, and why they believe the most interesting questions are only just being asked.Discussed on the episode:The question Holly and Jim never imagined asking in their careers, and why the answer may change what "success" meansWhy a tool once thought impossible outside the operating room is now in the hands of manyThe appetite finding that went against everything they'd taught about the body's backup systemsWhat the medications haven't changed (so far), and why that disappointed one of them more than it surprised themA hormone-based therapy with a risk profile that Holly says doesn't behave the way hormones usually doThe hidden "background noise" that patients only noticed once it was gone, and the swing Holly predicts is coming nextWhy so many people walk away from a treatment that works, and the two-track approach Jim and Holly take to thatOne medication, a surprisingly long list of possible uses, and a few that may raise your eyebrowsWhy Jim believes weight loss and successful obesity treatment may not be the same thingTheir predictions for what will surprise us five and ten years from now

You’ve hit your goal weight, or you’re close. So why doesn’t life feel as different as you expected? For many people, the number on the scale was never really the point. It was a stand-in for feeling confident, joining in, and finally enjoying life.Today’s weight loss medications are helping people lose weight that once felt out of reach. A large new BMJ analysis asked whether quality of life is keeping pace, and the answer may make you rethink what success means. Join Holly and Jim as they dig into the findings, why feeling better and weighing less don’t always move together, and share what they’d do about it.You’ll leave with practical, doable steps you can start now, long before you reach your goal weight. Press play to find out what to work on alongside your weight loss.Discussed on the episode:What a huge new review of nearly 100,000 participants revealed about weight loss and quality of lifeThe surprising gap between how much weight people lose and how much better life getsWhy “quality of life” and “happiness” aren’t quite the same thing, and why the difference mattersThe question Holly asks every patient that gets underneath the number they say they wantWhy waiting to be happy until you reach your goal could work against you.A simple fill-in-the-blank exercise to uncover what you really want your weight loss to make possibleThe “life score” you may want to track alongside your weightFeeling better but being disappointed is completely normal, and what to do if the medication itself is part of the problem.A rapid-fire round that puts the hosts on the spot, including a food noise question Holly says isn’t fair.The pattern Holly admits she’s guilty of, and what it means for celebrating your winsResources mentioned:Nong et al., "Comparative Effects of Drugs for Adults with Overweight or Obesity: A Systematic Review and Network Meta-Analysis," BMJ (2026).*Losing the Weight Loss Meds* book by James Hill and Holly WyattWeight Loss And… Episode 147: The Weight Comes Off Easy. Now What?Weight Loss And… Episode 146: Losing Weight on GLP-1s: Are You Moving More or Less Than Before?Weight Loss And… Episode 145: Are You Eating Healthier While Eating Less on GLP-1 Medications?

Your friend just started semaglutide. She got it online; it's "compounded," it has B12 in it, and it's only $199 a month. Sounds like a great deal, right? But what exactly is in that vial, who made it, and how much are you supposed to take? More and more people are facing these questions every day, and most of us don't know how to answer them.Join Holly and Jim as they welcome not one, not two, but three guests for the very first time: Misty Gaddis, pharmacy manager of medication compounding safety; Jessica Pescatore, clinical director of the Alabama Poison Information Center; and Richelle Chambliss, a clinical pharmacist who supports UAB's weight management clinics. Together, they pull back the curtain on compounded GLP-1s and share what your pharmacist wants you to know about weight loss medications, from dosing and side effects to insurance, access, and stopping and restarting. You'll come away with practical questions to ask and red flags to watch for before you inject anything.Discussed on the episode:Why "compounded" doesn't mean "generic," and the common misconception that could put you at riskThe real reason B12 shows up in so many online semaglutide products (and whether it's doing anything for your weight loss)What the Poison Center hears when dosing goes wrong, and why compounded products create a whole new level of riskThe surprising truth about why the cheapest option may not be the cheapest for longA tempting shortcut to save money that pharmacists urge you not to takeWhy the "best" dose may not be the highest oneWhat can happen when you stop and restart your medication on your ownThe red flags that should make you pause before taking anything you've ordered onlineThe underrated ways your pharmacist can help you succeed, and when to call themA question Holly and Jim have never asked in decades of weight loss work, and why it's now on the table

New obesity medications can now produce weight loss once thought impossible without surgery. That success is forcing doctors to ask a question they never had to face before: what if a treatment doesn't know when to stop?Join Holly and Jim as they unpack six new questions these next-generation drugs have raised in obesity medicine. Using a relatable patient case, they explore the difference between losing the maximum amount of weight and losing the optimal amount, and why those two things are no longer the same. You'll also hear where lifestyle fits into treatment now, what "success" really means when the scale isn't the whole story, and why the answers may ultimately come down to a conversation between patient and provider.Discussed on the episode:Why hitting the weight-loss "ceiling" used to save doctors from a decision they never had to makeA patient case that reveals what happens when someone loses more weight than she may actually needThe hidden trade-off between the number on the scale and what's happening to muscle and strengthWhy nutrition and physical activity haven't become less important on these medications, just differentThe rapid-fire round that puts Holly and Jim on the spot with some of obesity medicine's toughest new dilemmas

If losing weight made movement easier, wouldn’t you naturally start moving more? It’s the kind of assumption that feels almost too obvious to question: shed 40 or 50 pounds, and your knees stop aching, the stairs get easier, and you’re out there living more. Holly and Jim certainly believed it. But in the age of GLP-1 medications, where rapid, substantial weight loss is now common, does this assumption still hold up?In this episode, Holly and Jim put that belief to the test with real data. Diving into three separate studies (including brand-new, cutting-edge research), they explore what happens to physical activity levels once people start losing weight on GLP-1s. The results might surprise you, and as Jim warns early on, they might leave you feeling a little deflated too. But stick around, because Holly and Jim don’t just deliver the bad news; they explain why it matters and what you can actually do about it.Discussed on the episodeThe surprising step-count numbers researchers found when they measured GLP-1 users with wearable devices and why the results left Jim unimpressed.What happened when scientists tracked the same people’s activity levels before and after starting a GLP-1 medication (hint: it wasn’t what anyone expected)Why a control group matters so much in this kind of research, and what’s still missing from the pictureThe difference between “free living” activity and structured exercise, and which one may be quietly decliningA few theories on why physical activity might dip on these medications, and why even Jim isn’t fully convinced by any of themFive practical strategies for making sure your activity level doesn’t get left behind while the pounds come offHolly and Jim’s honest, personal reactions to research that challenges something they’ve believed for years